Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Ending Closing Price of NVS ADR on NYSE by Year
Ending Closing Price of NVS ADR on NYSE (USD/ADR) ($)
Novartis Ending Closing Price of NVS ADR on NYSE: $138 in FY2025, up 41.7% from a year earlier.
Latest, FY2025
138
Period ended Dec 31, 2025
Change on a year earlier
+41.7%
97.31 in FY2024
History
7 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
“|| ADR price (USD) | 137.87 | 97.31”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Ending Closing Price of NVS ADR on NYSE (USD/ADR) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 138 | +41.7% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 97.31 | -3.6% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2023 | Dec 31, 2023 | 101 | – | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 87.47 | -7.4% | Novartis Form 6-K (0001370368-22-000009) ↗ |
| FY2020 | Dec 31, 2020 | 94.43 | -0.3% | Novartis Form 6-K (0001370368-21-000008) ↗ |
| FY2019 | Dec 31, 2019 | 94.69 | +10.3% | Novartis Form 6-K (0001370368-20-000007) ↗ |
| FY2018 | Dec 31, 2018 | 85.81 | – | Novartis Form 6-K (0001370368-19-000006) ↗ |
Cite this data
StockData. (2026). Novartis Ending Closing Price of NVS ADR on NYSE ($), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/share-price-adr-usd
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.